C Michael Knudson

Title: C Michael Knudson: Innovator in Malignant Hyperthermia Diagnosis

Introduction

C Michael Knudson is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of malignant hyperthermia susceptibility. With a total of 2 patents, his work has the potential to impact patient care and safety.

Latest Patents

C Michael Knudson's latest patents focus on diagnosing malignant hyperthermia susceptibility. The first patent describes a method for diagnosing this condition by detecting abnormal ryanodine receptor fragments following proteolytic enzyme digestion of ryanodine receptors isolated from the sarcoplasmic reticulum of mammalian skeletal muscle. The detection of these abnormal fragments is indicative of malignant hyperthermia susceptibility. This innovative approach aims to enhance the accuracy of diagnoses and improve patient outcomes.

Career Highlights

Throughout his career, C Michael Knudson has been associated with reputable institutions such as the University of Iowa Research Foundation and the Regents of the University of Minnesota. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

C Michael Knudson has collaborated with esteemed colleagues, including Steven D Kahl and James R Mickelson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

C Michael Knudson's contributions to the field of malignant hyperthermia diagnosis exemplify the importance of innovation in medical science. His patents and collaborations reflect a commitment to improving healthcare through advanced diagnostic methods.